GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jacobio Pharmaceuticals Group Co Ltd (HKSE:01167) » Definitions » Shares Outstanding (EOP)

Jacobio Pharmaceuticals Group Co (HKSE:01167) Shares Outstanding (EOP) : 791.76 Mil (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Jacobio Pharmaceuticals Group Co Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Jacobio Pharmaceuticals Group Co's shares outstanding for the quarter that ended in Dec. 2023 was 791.76 Mil.

Jacobio Pharmaceuticals Group Co's quarterly shares outstanding declined from Jun. 2023 (793.56 Mil) to Dec. 2023 (791.76 Mil). It means Jacobio Pharmaceuticals Group Co bought back shares from Jun. 2023 to Dec. 2023 .

Jacobio Pharmaceuticals Group Co's annual shares outstanding increased from Dec. 2022 (771.46 Mil) to Dec. 2023 (791.76 Mil). It means Jacobio Pharmaceuticals Group Co issued new shares from Dec. 2022 to Dec. 2023 .


Jacobio Pharmaceuticals Group Co Shares Outstanding (EOP) Historical Data

The historical data trend for Jacobio Pharmaceuticals Group Co's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jacobio Pharmaceuticals Group Co Shares Outstanding (EOP) Chart

Jacobio Pharmaceuticals Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Outstanding (EOP)
Get a 7-Day Free Trial 759.65 759.65 771.46 771.46 791.76

Jacobio Pharmaceuticals Group Co Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 771.46 771.46 771.46 793.56 791.76

Competitive Comparison of Jacobio Pharmaceuticals Group Co's Shares Outstanding (EOP)

For the Biotechnology subindustry, Jacobio Pharmaceuticals Group Co's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jacobio Pharmaceuticals Group Co's Shares Outstanding (EOP) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jacobio Pharmaceuticals Group Co's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Jacobio Pharmaceuticals Group Co's Shares Outstanding (EOP) falls into.



Jacobio Pharmaceuticals Group Co Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Jacobio Pharmaceuticals Group Co  (HKSE:01167) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Jacobio Pharmaceuticals Group Co Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Jacobio Pharmaceuticals Group Co's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Jacobio Pharmaceuticals Group Co (HKSE:01167) Business Description

Traded in Other Exchanges
Address
No. 88, Kechuang 6th Street, Building F2, Beijing Economic-Technological Development Area, Beijing, CHN
Jacobio Pharmaceuticals Group Co Ltd is a clinical-stage pharmaceutical company focusing on the in-house discovery and development of innovative oncology therapies.
Executives
Shen Zhu 2501 Other
Treasure Partner International Limited 2501 Other
Ultimate Estate Limited 2201 Interest of corporation controlled by you
Wang Yinxiang 2501 Other
Wang Xiaojie 2307 Founder of a discretionary trust who can infl
Hu Yunyan 2501 Other
Yakovpharma Ltd 2501 Other
Willgenpharma Ltd 2501 Other
Risepharma Ltd 2101 Beneficial owner
Johwpharma Ltd 2501 Other
Hmed Ltd 2501 Other
Gloryviewpharma Ltd 2501 Other
Honourpharma Ltd 2501 Other
Blesspharma Ltd 2501 Other
Hillhouse Investment Management, Ltd. 2102 Investment manager

Jacobio Pharmaceuticals Group Co (HKSE:01167) Headlines

No Headlines